Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.54K Sell
40
-84
-68% -$8.33K ﹤0.01% 738
2026
Q1
$11.7K Buy
124
+36
+41% +$3.59K ﹤0.01% 502
2025
Q4
$8.69K Buy
88
+48
+120% +$4.64K ﹤0.01% 599
2025
Q3
$3.39K Buy
40
+11
+38% +$869 ﹤0.01% 749
2025
Q2
$1.98K Sell
29
-63
-68% -$3.99K ﹤0.01% 814
2025
Q1
$5.57K Hold
92
﹤0.01% 600
2024
Q4
$6.36K Sell
92
-60
-39% -$4.28K ﹤0.01% 544
2024
Q3
$10K Buy
152
+123
+424% +$7.84K 0.01% 457
2024
Q2
$1.76K Buy
+29
New +$1.64K ﹤0.01% 769
2024
Q1
Sell
-153
Closed -$9.61K 897
2023
Q4
$9.61K Buy
+153
New +$8.65K 0.01% 428

Other funds holding INCY

WealthCollab's INCY Position: Q2 2026 in Review

WealthCollab reduced its Incyte (INCY) stake by 68% in Q2 2026, selling an estimated $8.33K and leaving 40 shares worth $4.54K. The position accounts for ﹤0.01% of the portfolio, ranked #738.

WealthCollab first reported a position in INCY in Q4 2023 and has held it in 10 quarters since. The position peaked at $11.7K in Q1 2026. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • WealthCollab held 40 shares of Incyte worth $4.54K as of Q2 2026.
  • WealthCollab sold 84 Incyte shares in Q2 2026, an estimated $8.33K.
  • Incyte made up ﹤0.01% of WealthCollab's portfolio in Q2 2026, its #738 holding.
  • WealthCollab first reported a position in Incyte in Q4 2023 and has held it in 10 quarters since.
  • WealthCollab's Incyte position peaked at $11.7K in Q1 2026.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.